Search Results for 'Patients-Dabigatran'

Patients-Dabigatran published presentations and documents on DocSlides.

Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia

Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia

by adah

NOAC vs Warfarin Atrial Fibrillation Studies – A...

Dabigatran in myocardial injury after noncardiac

Dabigatran in myocardial injury after noncardiac

by lois-ondreau

surgery. Dr. PJ Devereaux on behalf of . MANAGE I...

NOACs vs. warfarin: Pros and Cons for Patients and Providers to Consider

NOACs vs. warfarin: Pros and Cons for Patients and Providers to Consider

by debby-jeon

Advantages of NOACs. No INR monitoring required. ...

DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag

DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag

by cecilia

Steven Johnston, BDS, MSc, MFDS RCS(Ed), Dental Of...

Safety and Efficacy of Uninterrupted Anticoagulation with

Safety and Efficacy of Uninterrupted Anticoagulation with

by olivia-moreira

Dabigatran . Etexilate versus Warfarin in Patient...

New (Direct)Oral anti-coagulants in the treatment of VTE

New (Direct)Oral anti-coagulants in the treatment of VTE

by ariel

Dr NA Smith - Haematology Dept. Heart of England...

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

by dsuser1

Christopher Granger, . MD. Sean Pokorney, MD. . D...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

by alexa-scheidler

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Update on the New Oral Anticoagulants

Update on the New Oral Anticoagulants

by sherrill-nordquist

Eliot Williams, MD PhD. Division of Hematology &a...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

by debby-jeon

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Novel Oral Anticoagulants

Novel Oral Anticoagulants

by natalia-silvester

(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...

by marina-yarberry

Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...

New Oral Anticoagulants: A Review

New Oral Anticoagulants: A Review

by phoebe-click

Babak Moini, MD. Veterans Affairs Hospital. Noon ...

Stroke, Bleeding, and

Stroke, Bleeding, and

by lois-ondreau

Mortality Risks . in . Elderly Medicare Beneficia...

The Novel Oral Anticoagulants

The Novel Oral Anticoagulants

by tatyana-admore

Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...

New Oral Anticoagulant

New Oral Anticoagulant

by mitsue-stanley

R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...

Direct Oral Anticoagulants

Direct Oral Anticoagulants

by debby-jeon

Eliot Williams, MD PhD. Division of Hematology &a...

An Update on Reversal Agents for NOACs: Where Are

An Update on Reversal Agents for NOACs: Where Are

by briana-ranney

We Now?. Moderator. Christian T. Ruff, MD, MPH. A...

Anisah Ahmad Pharmacist

Anisah Ahmad Pharmacist

by genevieve

01904 72(4328). Anticoagulants . Warfarin . Novel ...

All things thrombosis Julie Wang

All things thrombosis Julie Wang

by GirlNextDoor

Thrombosis Fellow. VTE is chronic disease. Recurre...

The thick and thin of it: Reviewing Anticoagulant Options

The thick and thin of it: Reviewing Anticoagulant Options

by oneill

Lanae Fox, . PharmD. , BCPS. I have no financial d...

by eve

Consultant HaematologistNewcastle Hospitals NHS Tr...

Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch

Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch

by daniella

www.RxFiles.ca June 2021 Drug / BRAND Vitamin K ...

Journal Club Jim Hoehns,

Journal Club Jim Hoehns,

by cheryl-pisano

Pharm.D. .. Edoxaban. Oral factor . Xa. inhibito...

ANTICOAGULATION Blake Wachter

ANTICOAGULATION Blake Wachter

by olivia-moreira

, MD, PhD . Monday Morning Conference. Oct 4, 201...

Thromboembolic protocols

Thromboembolic protocols

by cecilia

& safe anticoagulant prescribing. July 2020. D...

by eddey

coronary intervention PCI1920 As new antithromboti...

OHDSI estimation-methods papers in progress

OHDSI estimation-methods papers in progress

by impristic

Martijn Schuemie, PhD. Janssen Research and Develo...

Pharmacology of Anticoagulants

Pharmacology of Anticoagulants

by conchita-marotz

Nathan Culver, . PharmD. , BCPS. anticoagulant Me...

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

by phoebe-click

NOACS IN AF. Where Do We Stand With NOACs in AF ...

The direct oral anticoagulants (DOACs)

The direct oral anticoagulants (DOACs)

by faustina-dinatale

and major trauma. Dr. Tina . Biss. Consultant . ...

Oral anticoagulants in the 21

Oral anticoagulants in the 21

by natalia-silvester

st. century: A practical guide to using newer A...

Concomitant Antiplatelet and OAC

Concomitant Antiplatelet and OAC

by kittie-lecroy

Tx. : . Real-World Practice. In the US, ~800,000 ...

Table Stock Incidence Malaysia Dialysis Patients Patients

Table Stock Incidence Malaysia Dialysis Patients Patients

by reece880

Sunita Bavanandan. Hooi Lai Seong. Ong Loke Meng. ...

Prevention of venous thromboembolism in surgical patients, medical patients and long-distance trave

Prevention of venous thromboembolism in surgical patients, medical patients and long-distance trave

by joy

Educational Slide Kit . American Society of Hemato...

Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients

Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients

by GratefulHeart

Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...

Immunizing Adult Patients Standards for PracticeYour patients trust y

Immunizing Adult Patients Standards for PracticeYour patients trust y

by payton

received all the vaccines they needEven though mos...

Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Y

Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Y

by debby-jeon

of . Age. . Hiromichi. Suzuki, Tsutomu . Inoue,...

Integrated care model For Vulnerable Patients in primary care

Integrated care model For Vulnerable Patients in primary care

by alessandro240

Gina Rowlands. Managing Director. Bevan Healthcare...

RAMP-UP: Pharmacist-led Rapid Access to Methadone Maintenance for Patients with OUD at Penn

RAMP-UP: Pharmacist-led Rapid Access to Methadone Maintenance for Patients with OUD at Penn

by zahir465

AMERSA 2023. November 1, 2023. Emily Casey, PharmD...